Vaxcyte Inc. (PCVX) Social Stream
VAXCYTE INC (PCVX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering VAXCYTE INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-13 | 3 | $55 | $45.001 | $50 | $62.8 | -20.38% |
| 2022-03-01 | 3 | $55 | $45 | $50 | $62.8 | -20.38% |
| 2022-09-30 | 2 | $55 | $37 | $47.333 | $62.8 | -24.63% |
| 2022-10-24 | 2 | $67 | $50 | $57.333 | $62.8 | -8.71% |
| 2022-10-26 | 3 | $67 | $50 | $57.333 | $62.8 | -8.71% |
| 2022-11-08 | 3 | $64 | $55 | $58.333 | $62.8 | -7.11% |
| 2022-11-17 | 4 | $70 | $56 | $64.75 | $62.8 | 3.11% |
| 2022-12-15 | 6 | $70 | $56 | $65 | $62.8 | 3.5% |
| 2022-12-16 | 6 | $70 | $56 | $64.166 | $62.8 | 2.18% |
| 2023-02-28 | 7 | $70 | $56 | $63.285 | $62.8 | 0.77% |
| 2023-04-17 | 6 | $70 | $56 | $63.142 | $62.8 | 0.54% |
| 2023-04-19 | 8 | $70 | $56 | $63.142 | $62.8 | 0.54% |
| 2023-05-10 | 8 | $70 | $56 | $63.285 | $62.8 | 0.77% |
| 2023-08-08 | 8 | $70 | $58 | $65.285 | $62.8 | 3.96% |
| 2023-08-09 | 8 | $70 | $58 | $65.428 | $62.8 | 4.18% |
| 2023-11-06 | 8 | $68 | $58 | $63.4 | $62.8 | 0.96% |
| 2023-11-07 | 8 | $70 | $58 | $65.142 | $62.8 | 3.73% |
| 2023-12-07 | 9 | $69 | $58 | $64.333 | $62.8 | 2.44% |
The Trend in the Analyst Price Target
Over the past 32 months, PCVX's average price target has gone up $16.08.
PCVX reports an average of 36.49% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-03 | 7 | 70 | 56 | 63.285 | 47.20 | 34.08% |
| 2023-01-26 | 7 | 70 | 56 | 63.285 | 46.89 | 34.96% |
| 2023-04-19 | 8 | 70 | 56 | 63.142 | 45.79 | 37.89% |
| 2023-05-10 | 8 | 70 | 56 | 63.285 | 52.33 | 20.93% |
| 2023-10-16 | 8 | 70 | 58 | 65.142 | 46.88 | 38.95% |
PCVX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.13 | 7 | 1 | 0 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
Over the past 28 months, PCVX's average broker recommendation rating worsened by 0.11.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- VAXCYTE INC's variance in analysts' estimates is lower than -405.18% of all US stocks.
- PCVX has a higher upside potential (average analyst target price relative to current price) than 289.75% of Pharmaceutical Products stocks.
- In the context of Pharmaceutical Products stocks, VAXCYTE INC's average analyst price target is greater than 1866.13% of them.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, VAXCYTE INC's number of analysts covering the stock is higher than 747.41% of them.
In the Pharmaceutical Products industry, SANA, AKRO, and NGM are the three stocks most similar to VAXCYTE INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding PCVX using the data that counts. Try POWR Ratings for free.